在患有心房动和慢性阻塞性肺病的患者中,低剂量阿齐思罗米辛预防
Tommaso Bucci1,2, Dennis Wat1,3, Sarah Sibley3
1Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK.
Internal and emergency medicine
|May 31, 2024
概括
低剂量的阿齐思罗米辛预防可能会降低慢性阻塞性肺病 (COPD) 和心房动 (AF) 患者的心血管和出血风险. 这一发现表明,阿齐思罗米可能有利于管理这些复杂的患者.
科学领域:
- 肺部医学 肺部医学
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 低剂量阿齐思罗米预防改善了慢性阻塞性肺病 (COPD) 频繁恶化的结果.
- 由于潜在的风险,在患有心血管疾病,特别是心房动 (AF) 的患者中使用宏类药物仍然存在争议.
研究的目的:
- 为了研究在接受阿齐思罗米辛预防治疗的AF患者中,COPD恶化后出现不良心血管和出血事件的风险.
主要方法:
- 使用TrinetX平台进行的回顾性队列研究,包括患有AF和COPD恶化的患者.
- 在阿兹罗密辛使用者和非使用者之间,对复合心血管和出血结局的30天风险的比较.
- 倾向性得分匹配 (PSM) 和考克斯回归分析用于比较结果.
主要成果:
- 在PSM后,与非使用者相比,阿兹罗米辛使用者对复合心血管 (HR 0.67) 和出血结局 (HR 0.45) 的30天风险显著降低.
- 阿齐思罗米的有益作用在大多数次要结局中是一致的,除了内出血 (ICH).
- 敏感性分析证实,不良事件的降低风险与吸烟状况,恶化严重程度和口服抗凝药类型无关.
结论:
- 在AF和COPD患者中,阿兹罗米辛预防与全因死亡,血栓和出血事件的风险降低有关.
- 需要进行进一步的研究,以探索阿齐思罗米预防在COPD的AF患者综合护理管理中的作用.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
195
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
195
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:19Antiasthma Drugs: Leukotriene Modifiers
276
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
276
01:17Drugs Used in Lower Respiratory Disorders: Overview
420
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
420
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K